These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32745092)

  • 1. Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial.
    Haac BE; O'Hara NN; Manson TT; Slobogean GP; Castillo RC; O'Toole RV; Stein DM;
    PLoS One; 2020; 15(8):e0235628. PubMed ID: 32745092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-discharge adherence with venous thromboembolism prophylaxis after orthopedic trauma: Results from a randomized controlled trial of aspirin versus low molecular weight heparin.
    Haac BE; Van Besien R; O'Hara NN; Slobogean GP; Manson TT; O'Toole RV; Johal H; Berger PZ; Reahl GB; Marinos D; Degani Y; Mascarenhas D; Connelly D; Scalea TM; Stein DM
    J Trauma Acute Care Surg; 2018 Apr; 84(4):564-574. PubMed ID: 29251700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PREVENTion of CLots in Orthopaedic Trauma (PREVENT CLOT): a randomised pragmatic trial protocol comparing aspirin versus low-molecular-weight heparin for blood clot prevention in orthopaedic trauma patients.
    O'Toole RV; Stein DM; Frey KP; O'Hara NN; Scharfstein DO; Slobogean GP; Taylor TJ; Haac BE; Carlini AR; Manson TT; Sudini K; Mullins CD; Wegener ST; Firoozabadi R; Haut ER; Bosse MJ; Seymour RB; Holden MB; Gitajn IL; Goldhaber SZ; Eastman AL; Jurkovich GJ; Vallier HA; Gary JL; Kleweno CP; Cuschieri J; Marvel D; Castillo RC;
    BMJ Open; 2021 Mar; 11(3):e041845. PubMed ID: 33762229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture.
    ; O'Toole RV; Stein DM; O'Hara NN; Frey KP; Taylor TJ; Scharfstein DO; Carlini AR; Sudini K; Degani Y; Slobogean GP; Haut ER; Obremskey W; Firoozabadi R; Bosse MJ; Goldhaber SZ; Marvel D; Castillo RC
    N Engl J Med; 2023 Jan; 388(3):203-213. PubMed ID: 36652352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin is more effective than aspirin in preventing early neurologic deterioration and improving six-month outcome.
    Yi X; Lin J; Wang C; Zhang B; Chi W
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1537-44. PubMed ID: 24656240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobile Compression Reduces Bleeding-related Readmissions and Wound Complications After THA and TKA.
    Arsoy D; Giori NJ; Woolson ST
    Clin Orthop Relat Res; 2018 Feb; 476(2):381-387. PubMed ID: 29529673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and effectiveness of aspirin and enoxaparin for venous thromboembolism prophylaxis after total hip and knee arthroplasty: a systematic review.
    Nadi S; Vreugdenburg TD; Atukorale Y; Ma N; Maddern G; Rovers M
    ANZ J Surg; 2019 Oct; 89(10):1204-1210. PubMed ID: 30989803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.
    Gritsiouk Y; Hegsted DA; Schlesinger P; Gardiner SK; Gubler KD
    Am J Surg; 2014 May; 207(5):648-51; discussion 651-2. PubMed ID: 24560359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.
    Cafri G; Paxton EW; Chen Y; Cheetham CT; Gould MK; Sluggett J; Bini SA; Khatod M
    J Arthroplasty; 2017 Nov; 32(11):3524-3528.e1. PubMed ID: 28634095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.
    Sun G; Wu J; Wang Q; Liang Q; Jia J; Cheng K; Sun G; Wang Z
    J Arthroplasty; 2019 Apr; 34(4):789-800.e6. PubMed ID: 30685261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide.
    Larocca A; Cavallo F; Bringhen S; Di Raimondo F; Falanga A; Evangelista A; Cavalli M; Stanevsky A; Corradini P; Pezzatti S; Patriarca F; Cavo M; Peccatori J; Catalano L; Carella AM; Cafro AM; Siniscalchi A; Crippa C; Petrucci MT; Yehuda DB; Beggiato E; Di Toritto TC; Boccadoro M; Nagler A; Palumbo A
    Blood; 2012 Jan; 119(4):933-9; quiz 1093. PubMed ID: 21835953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
    Sarasin FP; Bounameaux H
    Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
    Lu X; Lin J
    BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.
    Jacobs BN; Cain-Nielsen AH; Jakubus JL; Mikhail JN; Fath JJ; Regenbogen SE; Hemmila MR
    J Trauma Acute Care Surg; 2017 Jul; 83(1):151-158. PubMed ID: 28426561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of aspirin in venous thromboembolism prevention after total hip arthroplasty, total knee arthroplasty or fracture.
    Jiang W; Yan Y; Huang T; Lin Z; Yang X; Luo Z; Ye L
    Vasa; 2024 Sep; 53(5):314-325. PubMed ID: 39052442
    [No Abstract]   [Full Text] [Related]  

  • 17. CRISTAL: protocol for a cluster randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested study.
    Sidhu VS; Graves SE; Buchbinder R; Naylor JM; Pratt NL; de Steiger RS; Chong BH; Ackerman IN; Adie S; Harris A; Hansen A; Cripps M; Lorimer M; Webb S; Clavisi O; Griffith EC; Anandan D; O'Donohue G; Kelly TL; Harris IA
    BMJ Open; 2019 Nov; 9(11):e031657. PubMed ID: 31699735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical venous thromboembolism prophylaxis in neurosurgical patients: an updated systematic review and meta-analysis.
    Khan NR; Patel PG; Sharpe JP; Lee SL; Sorenson J
    J Neurosurg; 2018 Oct; 129(4):906-915. PubMed ID: 29192859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients.
    Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A
    J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.